Silo Pharma, Inc. (SILO) Files Proxy Statement Ahead of Shareholder Meeting
Filing Details Silo Pharma, Inc. (NASDAQ:SILO) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on June 30, 2026. The Healthcare company's…
Read more
